News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
SC pembrolizumab demonstrated noninferiority compared with IV pembrolizumab in the phase III MK-3475A-D77 trial – ESMO
European Society for Medical Oncology/LinkedIn
Mar 27, 2025, 14:45

SC pembrolizumab demonstrated noninferiority compared with IV pembrolizumab in the phase III MK-3475A-D77 trial – ESMO

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“As presented at ELCC25, subcutaneous (SC) pembrolizumab – consisting of pembrolizumab co-formulated with berahyaluronidase alfa – demonstrated noninferiority in pharmacokinetics compared with intravenous (IV) pembrolizumab in the phase III MK-3475A-D77 trial. Similar efficacy outcomes were observed.

Patients may prefer SC immunotherapy administration and other potential benefits include reductions in pharmacy preparation, nursing administration time, infusion-chair occupancy and infusion-related adverse events than with IV administration.

Results plus commentary in the ESMO Daily Reporter.”

berahyaluronidase alfa cancer ELCC25 ESMO ESMODailyReporter European Society for Medical Oncology fight against cancer Global fight against cancer IV MK-3475A-D77 trial OncoDaily Oncology pembrolizumab Subcutaneous pembrolizumab
Special Coverage
Insight
Apr 3, 2025, 04:43
Can engineered bacteria revolutionize cancer treatment? - Cancer Research Institute
Blog
Apr 3, 2025, 04:21
Double your impact for kids fighting cancer - National Foundation for Cancer Research
Blog
Apr 3, 2025, 03:54
Lucjan Wyrwicz: 300 plus citations last month
Career
Apr 3, 2025, 03:37
Jeff Molter: I’m starting a new position as Health communications consultant at Self
Blog
Apr 3, 2025, 03:19
Join MENA Conference at the Emirates Pediatric Hematology and Oncology Conference
Blog
Apr 3, 2025, 03:06
Ricardo Baptista Leite: Patients can get better health outcomes from the power of Artificial Intelligence
Blog
Apr 3, 2025, 02:35
Entero Policy Event is coming up this month - Digestive Cancers Europe
Blog
Apr 3, 2025, 02:23
E. Shyam P. Reddy: Protein That Calms Waking Hair Follicles Could Lead to Alopecia Treatment
Blog
Apr 3, 2025, 01:51
Antonio Giordano: Sharon Burk has completed her PhD on The Role of Cyclin Dependent Kinase 10 in Triple Negative Breast Cancer
Career
Apr 3, 2025, 01:40
Last Chance to Apply for CRUK Black Leaders in Cancer PhD Scholarship Programme - Manchester Cancer Research Centre
Blog
Apr 3, 2025, 01:21
Sarah Louden: Ten Years, One Country, Five Moments
Career
Apr 3, 2025, 01:00
Professor Maria Kavallaris, has been inducted into the AIMBE College of Fellows - Children's Cancer Institute